We are live on
!
Find out more
FPF
FNY Partners Fund Portfolio holdings
AUM
$185M
Turnover
75.98%
1-Year Est. Return
32.58%
This Fund
S&P 500
This Quarter
Est. Return
+14.16%
1 Year Est. Return
+32.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$588M
AUM Growth
+$175M
(+42%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
20.16%
Top 10 Holdings %
Top 10 Hldgs %
54.34%
Holding
835
New
294
Increased
101
Reduced
91
Closed
281
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.1
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$52.9M |
| 2 |
British American Tobacco
BTI
|
+$40.5M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$36.4M |
| 4 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
+$22.3M |
| 5 |
ALR
Alere Inc
ALR
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allied World Assurance Co Hld Lt
AWH
|
+$54.6M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$27.3M |
| 3 |
AABA
Altaba Inc
AABA
|
+$24.9M |
| 4 |
Mobileye N.V.
MBLY
|
+$17.2M |
| 5 |
TechnipFMC
FTI
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.11% |
| 2 | Technology | 14.68% |
| 3 | Communication Services | 11.2% |
| 4 | Financials | 9.54% |
| 5 | Consumer Staples | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
CALL
DXC Technology
DXC
$2.2B
| $107K | 0.02% |
1,453
+195
| +16% | +$13.8K |
2017 Q2
1 quarter
|
|
202
Costamare
CMRE
$1.73B
| $106K | 0.02% |
+17,244
| New | +$112K |
2017 Q3
0 quarters
|
|
|
COL
203
DELISTED
Rockwell Collins
COL
| $104K | 0.02% |
+800
| New | +$97.2K |
2017 Q3
0 quarters
|
|
204
Molina Healthcare
MOH
$11.1B
| $103K | 0.02% |
1,500
-5,000
| -77% | -$325K |
2017 Q1
2 quarters
|
|
|
BKS
205
DELISTED
Barnes & Noble
BKS
| $102K | 0.02% |
+13,500
| New | +$101K |
2017 Q3
0 quarters
|
|
|
NEFF
206
DELISTED
Neff Corporation
NEFF
| $102K | 0.02% |
+4,093
| New | +$93.9K |
2017 Q3
0 quarters
|
|
207
Curis
CRIS
$1.23M
| $100K | 0.02% |
34
+26
| +325% | +$96.1K |
2016 Q4
3 quarters
|
|
208
Omnicom Group
OMC
$22.1B
| $98K | 0.02% |
+1,330
| New | +$102K |
2017 Q3
0 quarters
|
|
209
Global Payments
GPN
$22.3B
| $95K | 0.02% |
1,001
+1,000
| +100,000% | +$94.2K |
2017 Q1
2 quarters
|
|
210
American Airlines Group
AAL
$8.13B
| $94K | 0.02% |
+2,000
| New | +$96.7K |
2017 Q3
0 quarters
|
|
211
RB Global
RBA
$16.1B
| $94K | 0.02% |
3,000
| – | – |
2017 Q2
1 quarter
|
|
|
CDK
212
DELISTED
CDK Global, Inc.
CDK
| $94K | 0.02% |
+1,500
| New | +$94.5K |
2017 Q3
0 quarters
|
|
|
MON
213
CALL
DELISTED
Monsanto Co
MON
| $93K | 0.02% |
784
-1
| -0.1% | -$118 |
2017 Q2
1 quarter
|
|
|
HRG
214
DELISTED
HRG Group, Inc.
HRG
| $93K | 0.02% |
6,000
| – | – |
2017 Q1
2 quarters
|
|
|
IPXL
215
DELISTED
Impax Laboratories, Inc.
IPXL
| $91K | 0.02% |
+4,500
| New | +$86K |
2017 Q3
0 quarters
|
|
216
PUT
Herbalife
HLF
$1.53B
| $90K | 0.02% |
+2,678
| New | +$91.7K |
2017 Q3
0 quarters
|
|
|
CY
217
DELISTED
Cypress Semiconductor
CY
| $90K | 0.02% |
6,000
-21,550
| -78% | -$302K |
2016 Q4
3 quarters
|
|
218
Keurig Dr Pepper
KDP
$46.5B
| $88K | 0.02% |
1,000
| – | – |
2017 Q2
1 quarter
|
|
219
Jazz Pharmaceuticals
JAZZ
$13.9B
| $87K | 0.01% |
+600
| New | +$90.7K |
2017 Q3
0 quarters
|
|
220
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.84B
| $83K | 0.01% |
746
-747
| -50% | -$83.2K |
2017 Q2
1 quarter
|
|
221
Himax Technologies
HIMX
$2.11B
| $81K | 0.01% |
7,500
-45,700
| -86% | -$415K |
2017 Q1
2 quarters
|
|
222
Mondelez International
MDLZ
$80.4B
| $81K | 0.01% |
2,000
| – | – |
2017 Q2
1 quarter
|
|
|
YUME
223
DELISTED
YuMe, Inc.
YUME
| $81K | 0.01% |
+17,648
| New | +$82.7K |
2017 Q3
0 quarters
|
|
|
SINA
224
DELISTED
Sina Corp
SINA
| $80K | 0.01% |
+700
| New | +$70.7K |
2017 Q3
0 quarters
|
|
225
Vanguard World Funds Extended Duration ETF
EDV
$3.75B
| $77K | 0.01% |
660
+234
| +55% | +$27.7K |
2017 Q2
1 quarter
|
|
Similar funds
USG2
PAM
HWP
IHM
EP
DVM
LCM
PAM
FNY Partners Fund's Q3 2017 Portfolio in Review
As of Q3 2017, FNY Partners Fund held 835 positions worth $588M, up 42% from $413M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
FNY Partners Fund deployed $118M of net new capital in Q3 2017, opening 294 new positions and adding to 101 existing holdings. Its largest new stake was Kite Pharma, Inc.: 379,510 shares worth $68.2M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 10% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Altaba Inc, an estimated $24.9M trimmed.
- FNY Partners Fund's largest Q3 2017 buy was Kite Pharma, Inc.: 379,510 shares worth $68.2M.
- FNY Partners Fund added most to Time Warner Inc in Q3 2017, an estimated $36.4M increase.
- FNY Partners Fund's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $24.9M.
- FNY Partners Fund fully exited Allied World Assurance Co Hld Lt in Q3 2017, selling an estimated $54.6M.
- FNY Partners Fund's ten largest holdings make up 54% of its $588M portfolio in Q3 2017.
- FNY Partners Fund opened 294 new positions and closed 281 in Q3 2017.
- FNY Partners Fund's portfolio value rose 42% quarter-over-quarter to $588M.
Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.